The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
The ENGAGE Initiative – The EuropeaN Guidelines for the mAnagement of Graft rEcipients– continues its mission to strengthen clinical practice and research in transplantation. Building on the foundations of ENGAGE I and ENGAGE II, we are pleased to announce the launch of ENGAGE III. This new phase focuses on one of the most pressing challenges in transplant medicine: antibody-mediated rejection (ABMR).
We are pleased to announce that the following ESOT Sections and Committees launched a call for nominations for new Board members: EKITA, ELITA, VCA, BSC, YPT
The Vascularized Composite Allotransplantation (VCA) Section is pleased to announce a call for nominations for four new Board members. The elected members will serve two years (2026-2028) with a maximum of two consecutive terms. One of the four positions is reserved for a professional working in the field of uterus transplantation.
YPT – The Young Professionals in Transplantation Committee – would like to announce a call for nominations for two Board members. The new YPT Board Members will hold office for four years (2026–2030), starting in September 2026.
BSC – the Basic Science Committee- would like to announce a call for nominations for one Board member. The new BSC Board Members will hold office for four years (2026-2030), starting in September 2026.
EKITA, the European Kidney Transplant Section of ESOT, would like to announce a call for nominations for one new Board member. The new EKITA Board Member will hold office for four years (2026-2030), starting in September 2026.
ELITA – the European Liver and Intestine Transplant Association – would like to announce a call for nominations for one new Board member. The new ELITA Board Member will hold office for four years (2026-2030), starting in September 2026.
A new Delphi initiative is seeking experienced clinicians in solid-organ transplantation to contribute to a European consensus project. The study will use structured, multi-round surveys to gather expert opinions, identify key challenges, and build consensus on current practices in the field. Findings will help inform future guidance and support harmonised care across Europe. Key points:
You are invited to take part in this survey, designed by a panel of CMV experts selected by ESOT. The findings will contribute to a scientific peer-reviewed publication and help build a clearer picture of real-world practice across transplant centres.
Chronic Lung Allograft Dysfunction (CLAD) remains one of the most serious long-term complications after lung transplantation. While transplantation can be life-saving,CLAD presents ongoing medical, physical, and emotional challenges for patients, caregivers, and healthcare professionals. Join our upcoming free webinar in the CLAD series! This expert-led session will provide an updated overview of the burden of CLAD, focusing
